Search research articles
Contact Us
Filters
Showing results (1-10 of 326) with videos related to
Page
of 33
Sort By:
World Journal of Gastroenterology
|
January 29, 2019
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
Wai-Kay Seto
World Journal of Hepatology
|
May 5, 2015
Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
Wai-Kay Seto
Clinical and Molecular Hepatology
|
March 24, 2025
Besifovir: a viable option for long-term disease control in chronic hepatitis B
Wai-Kay Seto
Gut
|
July 29, 2025
Partial cure of chronic hepatitis B: potential implications for HCC surveillance?
Wai-Kay Seto, Anna Lok
Journal of Gastroenterology
|
September 18, 2016
Nonalcoholic fatty liver disease in Asia: emerging perspectives
Wai-Kay Seto, Man-Fung Yuen
Nature Reviews. Gastroenterology & Hepatology
|
September 15, 2016
Viral hepatitis: 'Immune tolerance' in HBV infection: danger lurks
Wai-Kay Seto, Man-Fung Yuen
Clinical Liver Disease
|
May 2, 2019
New pharmacological approaches to a functional cure of hepatitis B
Wai-Kay Seto, Man-Fung Yuen
The American Journal of Gastroenterology
|
June 3, 2017
Response to Toyoda et al
Wai-Kay Seto, Man-Fung Yuen
Hepatology (Baltimore, Md.)
|
July 21, 2025
Unraveling the metabolic thread: Type 2 diabetes and fibrosis in chronic hepatitis B with steatosis
Won-Mook Choi, Wai-Kay Seto
Plos One
|
January 4, 2021
Chronic liver disease: Global perspectives and future challenges to delivering quality health care
Wai-Kay Seto, M Susan Mandell
Page
of 33
Search research articles
Search
Showing results (1-10 of 326) with videos related to
Sort By:
Page
of 33
World Journal of Gastroenterology
|
January 29, 2019
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
Wai-Kay Seto
World Journal of Hepatology
|
May 5, 2015
Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
Wai-Kay Seto
Clinical and Molecular Hepatology
|
March 24, 2025
Besifovir: a viable option for long-term disease control in chronic hepatitis B
Wai-Kay Seto
Gut
|
July 29, 2025
Partial cure of chronic hepatitis B: potential implications for HCC surveillance?
Wai-Kay Seto, Anna Lok
Journal of Gastroenterology
|
September 18, 2016
Nonalcoholic fatty liver disease in Asia: emerging perspectives
Wai-Kay Seto, Man-Fung Yuen
Nature Reviews. Gastroenterology & Hepatology
|
September 15, 2016
Viral hepatitis: 'Immune tolerance' in HBV infection: danger lurks
Wai-Kay Seto, Man-Fung Yuen
Clinical Liver Disease
|
May 2, 2019
New pharmacological approaches to a functional cure of hepatitis B
Wai-Kay Seto, Man-Fung Yuen
The American Journal of Gastroenterology
|
June 3, 2017
Response to Toyoda et al
Wai-Kay Seto, Man-Fung Yuen
Hepatology (Baltimore, Md.)
|
July 21, 2025
Unraveling the metabolic thread: Type 2 diabetes and fibrosis in chronic hepatitis B with steatosis
Won-Mook Choi, Wai-Kay Seto
Plos One
|
January 4, 2021
Chronic liver disease: Global perspectives and future challenges to delivering quality health care
Wai-Kay Seto, M Susan Mandell
Page
of 33